These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35109719)

  • 1. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
    Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation.
    Hagras M; El Deeb MA; Elzahabi HSA; Elkaeed EB; Mehany ABM; Eissa IH
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):640-658. PubMed ID: 33588683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
    Wang SY; Liu X; Meng LW; Li MM; Li YR; Yu GX; Song J; Zhang HY; Chen P; Zhang SY; Hu T
    Bioorg Med Chem Lett; 2021 Jul; 43():128095. PubMed ID: 33965530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors.
    Sardaru MC; Craciun AM; Al Matarneh CM; Sandu IA; Amarandi RM; Popovici L; Ciobanu CI; Peptanariu D; Pinteala M; Mangalagiu II; Danac R
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1581-1595. PubMed ID: 32752898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity.
    Liu K; Mo M; Yu G; Yu J; Song SM; Cheng S; Li HM; Meng XL; Zeng XP; Xu GC; Luo H; Xu BX
    Bioorg Chem; 2023 Oct; 139():106727. PubMed ID: 37451147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.
    Ibrahim TS; Hawwas MM; Malebari AM; Taher ES; Omar AM; Neamatallah T; Abdel-Samii ZK; Safo MK; Elshaier YAMM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):802-818. PubMed ID: 33730937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment.
    Abdel-Motaal M; Aldakhili DA; Abo Elmaaty A; Sharaky M; Mourad MAE; Alzahrani AYA; Mohamed NA; Al-Karmalawy AA
    Drug Dev Res; 2024 Jun; 85(4):e22197. PubMed ID: 38751223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors.
    Baytas SN; Inceler N; Yilmaz A; Olgac A; Menevse S; Banoglu E; Hamel E; Bortolozzi R; Viola G
    Bioorg Med Chem; 2014 Jun; 22(12):3096-104. PubMed ID: 24816066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytotoxic natural compound erianin binds to colchicine site of β-tubulin and overcomes taxane resistance.
    Yan W; Zhou Y; Yuan X; Bai P; Tang M; Chen L; Wei H; Yang J
    Bioorg Chem; 2024 Sep; 150():107569. PubMed ID: 38905886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.
    Li SS; Chen JJ; Zhang MM; Wang WX; Zhang WY; Ma C
    Eur J Med Chem; 2024 May; 271():116425. PubMed ID: 38636129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization.
    Ezelarab HAA; Ali TFS; Abbas SH; Sayed AM; Beshr EAM; Hassan HA
    Mol Divers; 2024 Apr; 28(2):563-580. PubMed ID: 36790582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the phenyl ring B of phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates by pyridinyl moiety leads to novel antimitotics targeting the colchicine-binding site.
    Ouellette V; Bouzriba C; Chavez Alvarez AC; Hamel-Côté G; Fortin S
    Bioorg Med Chem Lett; 2024 Jun; 105():129745. PubMed ID: 38614151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities.
    Tian XY; Zhang WX; Chen XY; Jia MQ; Zhang SY; Chen YF; Yuan S; Song J; Li J
    Eur J Med Chem; 2024 Feb; 265():116079. PubMed ID: 38150962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of new carbazole sulfonamide derivatives as anticancer agents with dual-target mechanism.
    Liu Y; Zhang J; Tian J; Wang C; Wang T; Gong J; Hu L
    Eur J Med Chem; 2024 Jul; 273():116509. PubMed ID: 38781920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 4-phenyl-5-quinolinyl substituted isoxazole analogues as potent cytotoxic and tubulin polymerization inhibitors against ESCC.
    Jia M; Pei Y; Li N; Zhang Y; Song J; Niu JB; Yang H; Zhang S; Sun M
    Eur J Med Chem; 2024 Sep; 275():116611. PubMed ID: 38901104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising anti-proliferative indolic benzenesulfonamides alter mechanisms with sulfonamide nitrogen substituents.
    Fuentes-Martín R; Ayuda-Durán P; Hanes R; Gallego-Yerga L; Wolterinck L; Enserink JM; Álvarez R; Peláez R
    Eur J Med Chem; 2024 Sep; 275():116617. PubMed ID: 38959729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and bioevaluation of 1
    Wang C; Zhang Y; Yang S; Shi L; Rong R; Zhang T; Wu Y; Xing D
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2302320. PubMed ID: 38221788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel β-Tubulin Inhibitors Using a Combined
    Horgan MJ; Zell L; Siewert B; Stuppner H; Schuster D; Temml V
    J Chem Inf Model; 2023 Oct; 63(20):6396-6411. PubMed ID: 37774242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy.
    Wu C; Zhang L; Zhou Z; Tan L; Wang Z; Guo C; Wang Y
    Eur J Med Chem; 2024 Oct; 276():116649. PubMed ID: 38972078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors.
    Tan Y; Hu H; Zhu W; Wang T; Gao T; Wang H; Chen J; Xu J; Xu S; Zhu H
    Eur J Med Chem; 2023 Dec; 262():115881. PubMed ID: 37883897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.